Effects of bile-acid-binding resin (colestimide) on blood glucose and visceral fat in Japanese patients with type 2 diabetes mellitus and hypercholesterolemia: An open-label, randomized, case-control, crossover study

Journal of Diabetes and its Complications

Volumn 26, Issue 1, 2012, Pages 34-39

  Suzuki, Tatsuya ^a   Oba, Kenzo ^a   Igari, Yoshimasa ^a   Watanabe, Kentaro ^a   Matsumura, Noriaki ^a   Futami Suda, Shoko ^a   Ouchi, Motoshi ^a   Suzuki, Kazunari ^a   Sekimizu, Ken Ichi ^a   Kigawa, Yoshiaki ^b   Nakano, Hiroshi ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b Hanno Geriatric Hospital   (Japan)

Author keywords

Blood glucose; Colestimide; Type 2 diabetes mellitus; Visceral fat

Indexed keywords

1,5 ANHYDROSORBITOL; 2,4 THIAZOLIDINEDIONE DERIVATIVE; ADIPOCYTOKINE; ALPHA GLUCOSIDASE INHIBITOR; BIGUANIDE; BILE ACID CONJUGATE; COLESTILAN; GLUCOSE; HEMOGLOBIN A1C; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PRAVASTATIN; STATIN;

AGED; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIABETIC PATIENT; DIET RESTRICTION; DISEASE ASSOCIATION; DRUG WITHDRAWAL; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERCHOLESTEROLEMIA; INTRAABDOMINAL FAT; JAPANESE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OPEN STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL;

AGED; ANTICHOLESTEREMIC AGENTS; ASIAN CONTINENTAL ANCESTRY GROUP; BILE ACIDS AND SALTS; BLOOD GLUCOSE; CHOLESTEROL, LDL; CROSS-OVER STUDIES; DEOXYGLUCOSE; DIABETES MELLITUS, TYPE 2; DRUG THERAPY, COMBINATION; EPICHLOROHYDRIN; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERCHOLESTEROLEMIA; IMIDAZOLES; INTRA-ABDOMINAL FAT; LIPIDS; MALE; MIDDLE AGED; RESINS, SYNTHETIC; SIMVASTATIN;

EID: 84862777009     PISSN: 10568727     EISSN: 1873460X     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2011.11.008     Document Type: Article

References (24)

1. J.F. Brensike, R.I. Levy, S.F. Kelsey, E.R. Passamani, J.M. Richardson, and I.K. Loh Effects of therapy with cholestyramine on progression of coronary arteriosclerosis: results of the NHLBI Type II Coronary Intervention Study Circulation 69 1984 313 324 (Pubitemid 14180337)
2. E.A. Brinton Novel pathway for glycemic control in type 2 diabetes: focus on bile acid modulation Diabetes, Obesity and Metabolism 10 2008 1004 1011
3. B. Cariou, D. Duran-Sandoval, F. Kuipers, and B. Staels Farnesoid receptor X: a new player in glucose metabolism? Endocrinology 146 2005 981 983 (Pubitemid 40289283)
4. A.M. Cypess, S. Lehman, G. Williams, I. Tal, D. Rodman, and A.B. Goldfine Identification and importance of brown adipose tissue in adult humans The New England Journal of Medicine 360 2009 1509 1517
5. K. Hara, M. Horikoshi, T. Yamauchi, H. Yago, O. Miyazaki, and H. Ebinuma Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome Diabetes Care 29 2006 1357 1362 (Pubitemid 44125935)
6. Y. Hata, H. Mabuchi, Y. Saito, H. Itakura, G. Egusa, and H. Ito Working Committee on JAS Guideline for Diagnosis and Treatment of Hyperlipidemia. Report of the Japan Atherosclerosis Society (JAS) guideline for diagnosis and treatment of hyperlipidemia in Japanese adults Journal of Atherosclerosis and Thrombosis 9 2002 1 27
7. G. Kajiyama, S. Tazuma, G. Yamashita, H. Ochi, H. Miura, and T. Mizuno Effect of MCI-196 on biliary lipids metabolism in patients with hypercholesterolemia Journal of Clinical Therapeutics & Medicine 12 1996 1349 1359 [in Japanese]
8. S. Katsuma, A. Hirasawa, and G. Tsujimoto Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1 Biochemical and Biophysical Research Communications 329 2005 386 390 (Pubitemid 40255465)
9. M. Kobayashi, H. Ikegami, T. Fujisawa, K. Nojima, Y. Kawabata, and S. Noso Prevention and treatment of obesity, insulin resistance, and diabetes by bile acid-binding resin Diabetes 56 2007 239 247
10. K. Koike, K. Murakami, N. Nozaki, K. Sugiura, and M. Inoue Colestilan: a new bile acid-sequestering resin, reduces bodyweight in postmenopausal women who have dieted unsuccessfully Drugs in R & D 6 2005 273 279
11. K. Kondo, and T. Kadowaki Colestilan monotherapy significantly improves glycaemic control and LDL cholesterol levels in patients with type 2 diabetes: a randomized double-blind placebo-controlled study Diabetes, Obesity and Metabolism 12 2010 246 251
12. R.I. Levy, J.F. Brensike, S.E. Epstein, S.F. Kelsey, E.R. Passamani, and J.M. Richardson The influence of changes in lipid values induced by cholestyramine and diet on progression of coronary artery disease: results of NHLBI Type II Coronary Intervention Study Circulation 69 1984 325 337 (Pubitemid 14180338)
13. R. Longo, C. Ricci, F. Masutti, R. Vidimari, L.S. Crocé, and L. Bercich Fatty infiltration of the liver. Quantification by 1H localized magnetic resonance spectroscopy and comparison with tomography Investigative Radiology 28 1993 297 302 (Pubitemid 24079682)
14. Y. Matsuzawa, T. Funahashi, and T. Nakamura Molecular mechanism of vascular disease in metabolic syndrome X Journal of Diabetes and Its Complications 16 2002 17 18 (Pubitemid 34168494)
15. MCI-196 study group Study on the usefulness of MCI-196 in patients with hypercholesterolemia-a between-group comparative study using cholestyramine as a reference drug Journal of Clinical Therapeutics & Medicine 12 1996 1641 1692 [in Japanese]
16. H. Sakakura, M. Suzuki, N. Kimura, H. Takeda, S. Nagata, and M. Maeda Simultaneous determination of bile acid in rat bile and serum by high-performance liquid chromatography Journal of Chromatography 621 1993 123 131
17. T. Suzuki, K. Oba, S. Futami, K. Suzuki, M. Ouchi, and Y. Igari Blood glucose-lowering activity of colestimide in patients with type 2 diabetes and hypercholesterolemia: a case-control study comparing colestimide with acarbose Journal of Nippon Medical School=Nihon Ika Daigaku zasshi 73 2006 277 284 (Pubitemid 44663094)
18. T. Suzuki, K. Oba, Y. Igari, N. Matsumura, K. Watanabe, and S. Futami-Suda Colestimide lowers plasma glucose levels and increases plasma glucagon-like PEPTIDE-1 (7-36) levels in patients with type 2 diabetes mellitus complicated by hypercholesterolemia Journal of Nippon Medical School=Nihon Ika Daigaku zasshi 74 2007 338 343 (Pubitemid 47523077)
19. T. Teramoto, A. Kashiwagi, H. Mabuchi, and J-LAP Investigators Status of lipid-lowering therapy prescribed based on recommendations in the 2002 report of the Japan. Atherosclerosis Society guideline for diagnosis and treatment of hyperlipidemia in Japanese Adults: a study of the Japan Lipid Assessment Program (J-LAP) Current Therapeutic Research 66 2005 80 95
20. The Examination Committee of Criteria for 'Obesity Disease' in Japan, Japan Society for the Study of Obesity New criteria for 'obesity disease' in Japan Circulation Journal: Official Journal of the Japanese Circulation Society 66 2002 987 992
21. M. Watanabe, S.M. Houten, C. Mataki, M.A. Christoffolete, B.W. Kim, and H. Sato Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation Nature 439 2006 484 489 (Pubitemid 43152840)
22. T. Yamakawa, T. Takano, H. Utsunomiya, K. Kadonosono, and A. Okamura Effect of colestimide therapy for glycemic control in type 2 diabetes mellitus with hypercholesterolemia Endocrine Journal 54 2007 53 58 (Pubitemid 46481671)
23. M. Yamaoka-Tojo, T. Tojo, R. Kosugi, Y. Hatakeyama, Y. Yoshida, and Y. Machida Effect of colestimide on reduction of body weight and waist circumference in metabolic syndrome patients with cardiovascular risk factors Vascular Disease Prevention 5 2008 183 189
24. F.J. Zieve, M.F. Kalin, S.L. Schwartz, M.R. Jones, and W.L. Baily Results of the Glucose-Lowering Effect of Welchol Study (GLOWS): a randomized, double-blind, placebo-controlled pilot study evaluating the effect of colesevelam hydrochloride on glycemic control in subjects with type 2 diabetes Clinical Therapeutics 29 2006 74 83 (Pubitemid 46414026)